İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 400 míkróg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 300 míkróg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 200 míkróg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 100 míkróg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

uni-pharma kleon tsetis pharmaceutical laboratories s.a. - thiamazolum inn - tafla - 5 mg

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.